ClinicalTrials.Veeva

Menu

Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis

F

Federal University of São Paulo

Status and phase

Unknown
Phase 4

Conditions

Peritoneal Dialysis
Renal Failure, End Stage

Treatments

Drug: Simvastatin

Study type

Interventional

Funder types

Other

Identifiers

NCT00291863
0089/04

Details and patient eligibility

About

This study will analyse the effect of simvastatin on endothelium dependent venodilation in chronic renal failure patients treated by peritoneal dialysis. The hypothesis is that patients will have a greater endothelium dependent venodilation after four months of simvastatin use.

Full description

This study will analyse the effect of simvastatin on endothelium dependent venodilation in chronic renal failure patients treated by peritoneal dialysis. The hypothesis is that patients will have a greater endothelium dependent venodilation after four months of simvastatin use.

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • end stage renal failure
  • peritoneal dialysis
  • LDL cholesterol > 100mg/dL
  • > 18 years and < 80 years

Exclusion criteria

  • using statin or nitrate
  • liver disease
  • diabetes mellitus

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Central trial contact

Maristela Bohlke, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems